Streptozotocin-Induced Diabetes Models: Pathophysiological Mechanisms and Fetal Outcomes
Glucose homeostasis is controlled by endocrine pancreatic cells, and any pancreatic disturbance can result in diabetes. Because 8% to 12% of diabetic pregnant women present with malformed fetuses, there is great interest in understanding the etiology, pathophysiological mechanisms, and treatment of...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2014/819065 |
id |
doaj-af1ad9df2eff429bac95fd019ab845e7 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
D. C. Damasceno A. O. Netto I. L. Iessi F. Q. Gallego S. B. Corvino B. Dallaqua Y. K. Sinzato A. Bueno I. M. P. Calderon M. V. C. Rudge |
spellingShingle |
D. C. Damasceno A. O. Netto I. L. Iessi F. Q. Gallego S. B. Corvino B. Dallaqua Y. K. Sinzato A. Bueno I. M. P. Calderon M. V. C. Rudge Streptozotocin-Induced Diabetes Models: Pathophysiological Mechanisms and Fetal Outcomes BioMed Research International |
author_facet |
D. C. Damasceno A. O. Netto I. L. Iessi F. Q. Gallego S. B. Corvino B. Dallaqua Y. K. Sinzato A. Bueno I. M. P. Calderon M. V. C. Rudge |
author_sort |
D. C. Damasceno |
title |
Streptozotocin-Induced Diabetes Models: Pathophysiological Mechanisms and Fetal Outcomes |
title_short |
Streptozotocin-Induced Diabetes Models: Pathophysiological Mechanisms and Fetal Outcomes |
title_full |
Streptozotocin-Induced Diabetes Models: Pathophysiological Mechanisms and Fetal Outcomes |
title_fullStr |
Streptozotocin-Induced Diabetes Models: Pathophysiological Mechanisms and Fetal Outcomes |
title_full_unstemmed |
Streptozotocin-Induced Diabetes Models: Pathophysiological Mechanisms and Fetal Outcomes |
title_sort |
streptozotocin-induced diabetes models: pathophysiological mechanisms and fetal outcomes |
publisher |
Hindawi Limited |
series |
BioMed Research International |
issn |
2314-6133 2314-6141 |
publishDate |
2014-01-01 |
description |
Glucose homeostasis is controlled by endocrine pancreatic cells, and any pancreatic disturbance can result in diabetes. Because 8% to 12% of diabetic pregnant women present with malformed fetuses, there is great interest in understanding the etiology, pathophysiological mechanisms, and treatment of gestational diabetes. Hyperglycemia enhances the production of reactive oxygen species, leading to oxidative stress, which is involved in diabetic teratogenesis. It has also been suggested that maternal diabetes alters embryonic gene expression, which might cause malformations. Due to ethical issues involving human studies that sometimes have invasive aspects and the multiplicity of uncontrolled variables that can alter the uterine environment during clinical studies, it is necessary to use animal models to better understand diabetic pathophysiology. This review aimed to gather information about pathophysiological mechanisms and fetal outcomes in streptozotocin-induced diabetic rats. To understand the pathophysiological mechanisms and factors involved in diabetes, the use of pancreatic regeneration studies is increasing in an attempt to understand the behavior of pancreatic beta cells. In addition, these studies suggest a new preventive concept as a treatment basis for diabetes, introducing therapeutic efforts to minimize or prevent diabetes-induced oxidative stress, DNA damage, and teratogenesis. |
url |
http://dx.doi.org/10.1155/2014/819065 |
work_keys_str_mv |
AT dcdamasceno streptozotocininduceddiabetesmodelspathophysiologicalmechanismsandfetaloutcomes AT aonetto streptozotocininduceddiabetesmodelspathophysiologicalmechanismsandfetaloutcomes AT iliessi streptozotocininduceddiabetesmodelspathophysiologicalmechanismsandfetaloutcomes AT fqgallego streptozotocininduceddiabetesmodelspathophysiologicalmechanismsandfetaloutcomes AT sbcorvino streptozotocininduceddiabetesmodelspathophysiologicalmechanismsandfetaloutcomes AT bdallaqua streptozotocininduceddiabetesmodelspathophysiologicalmechanismsandfetaloutcomes AT yksinzato streptozotocininduceddiabetesmodelspathophysiologicalmechanismsandfetaloutcomes AT abueno streptozotocininduceddiabetesmodelspathophysiologicalmechanismsandfetaloutcomes AT impcalderon streptozotocininduceddiabetesmodelspathophysiologicalmechanismsandfetaloutcomes AT mvcrudge streptozotocininduceddiabetesmodelspathophysiologicalmechanismsandfetaloutcomes |
_version_ |
1725812690809520128 |
spelling |
doaj-af1ad9df2eff429bac95fd019ab845e72020-11-24T22:09:18ZengHindawi LimitedBioMed Research International2314-61332314-61412014-01-01201410.1155/2014/819065819065Streptozotocin-Induced Diabetes Models: Pathophysiological Mechanisms and Fetal OutcomesD. C. Damasceno0A. O. Netto1I. L. Iessi2F. Q. Gallego3S. B. Corvino4B. Dallaqua5Y. K. Sinzato6A. Bueno7I. M. P. Calderon8M. V. C. Rudge9Laboratory of Experimental Research on Gynecology and Obstetrics, Graduate Program in Gynecology, Obstetrics and Mastology, Botucatu Medical School, UNESP-Universidade Estadual Paulista, Distrito de Rubião Júnior S/N, 18618-970 Botucatu, SP, BrazilLaboratory of Experimental Research on Gynecology and Obstetrics, Graduate Program in Gynecology, Obstetrics and Mastology, Botucatu Medical School, UNESP-Universidade Estadual Paulista, Distrito de Rubião Júnior S/N, 18618-970 Botucatu, SP, BrazilLaboratory of Experimental Research on Gynecology and Obstetrics, Graduate Program in Gynecology, Obstetrics and Mastology, Botucatu Medical School, UNESP-Universidade Estadual Paulista, Distrito de Rubião Júnior S/N, 18618-970 Botucatu, SP, BrazilLaboratory of Experimental Research on Gynecology and Obstetrics, Graduate Program in Gynecology, Obstetrics and Mastology, Botucatu Medical School, UNESP-Universidade Estadual Paulista, Distrito de Rubião Júnior S/N, 18618-970 Botucatu, SP, BrazilLaboratory of Experimental Research on Gynecology and Obstetrics, Graduate Program in Gynecology, Obstetrics and Mastology, Botucatu Medical School, UNESP-Universidade Estadual Paulista, Distrito de Rubião Júnior S/N, 18618-970 Botucatu, SP, BrazilLaboratory of Experimental Research on Gynecology and Obstetrics, Graduate Program in Gynecology, Obstetrics and Mastology, Botucatu Medical School, UNESP-Universidade Estadual Paulista, Distrito de Rubião Júnior S/N, 18618-970 Botucatu, SP, BrazilLaboratory of Experimental Research on Gynecology and Obstetrics, Graduate Program in Gynecology, Obstetrics and Mastology, Botucatu Medical School, UNESP-Universidade Estadual Paulista, Distrito de Rubião Júnior S/N, 18618-970 Botucatu, SP, BrazilLaboratory of Experimental Research on Gynecology and Obstetrics, Graduate Program in Gynecology, Obstetrics and Mastology, Botucatu Medical School, UNESP-Universidade Estadual Paulista, Distrito de Rubião Júnior S/N, 18618-970 Botucatu, SP, BrazilLaboratory of Experimental Research on Gynecology and Obstetrics, Graduate Program in Gynecology, Obstetrics and Mastology, Botucatu Medical School, UNESP-Universidade Estadual Paulista, Distrito de Rubião Júnior S/N, 18618-970 Botucatu, SP, BrazilLaboratory of Experimental Research on Gynecology and Obstetrics, Graduate Program in Gynecology, Obstetrics and Mastology, Botucatu Medical School, UNESP-Universidade Estadual Paulista, Distrito de Rubião Júnior S/N, 18618-970 Botucatu, SP, BrazilGlucose homeostasis is controlled by endocrine pancreatic cells, and any pancreatic disturbance can result in diabetes. Because 8% to 12% of diabetic pregnant women present with malformed fetuses, there is great interest in understanding the etiology, pathophysiological mechanisms, and treatment of gestational diabetes. Hyperglycemia enhances the production of reactive oxygen species, leading to oxidative stress, which is involved in diabetic teratogenesis. It has also been suggested that maternal diabetes alters embryonic gene expression, which might cause malformations. Due to ethical issues involving human studies that sometimes have invasive aspects and the multiplicity of uncontrolled variables that can alter the uterine environment during clinical studies, it is necessary to use animal models to better understand diabetic pathophysiology. This review aimed to gather information about pathophysiological mechanisms and fetal outcomes in streptozotocin-induced diabetic rats. To understand the pathophysiological mechanisms and factors involved in diabetes, the use of pancreatic regeneration studies is increasing in an attempt to understand the behavior of pancreatic beta cells. In addition, these studies suggest a new preventive concept as a treatment basis for diabetes, introducing therapeutic efforts to minimize or prevent diabetes-induced oxidative stress, DNA damage, and teratogenesis.http://dx.doi.org/10.1155/2014/819065 |